alumni: Creating, Funding and Growing Innovative Healthcare Companies
Tuesday, March 27, 2018
6:00PM - 8:30PM
Location
JB Duke Hotel
Ballroom A-B
230 Science Drive
Durham, North Carolina 27708, United States
Description
Please join us for a robust discussion on the current trends impacting investment and funding of biomedical research and innovation. Hear from investors and participants across the biopharma ecosystem on the current challenges and opportunities of funding innovation at all stages of the innovation continuum -- from early research through late stage development and commercialization. The promise of science is exploding: gene therapy and gene editing offer potential cures; breakthroughs in understanding the human genome provide clues to more effectively develop targeted therapies; advances in harnessing the immune system to fight cancer are encouraging. As science progresses, how is the model for creating and financing these advancements evolving? Will the rapidly changing pricing and reimbursements dynamics for biomedical innovation continue to reward the entrepreneurs and innovators that take the risks to test and gain approval of new therapies? Join us and hear from a panel of experts that have focused much of their professional careers at the intersection of business, science and medicine.
Contact Name
Grace Taylor A.B. '91, P '18
Tuesday, March 27, 2018
6:00PM - 8:30PM
Location
JB Duke Hotel
Ballroom A-B
230 Science Drive
Durham, North Carolina 27708, United States
Description
Please join us for a robust discussion on the current trends impacting investment and funding of biomedical research and innovation. Hear from investors and participants across the biopharma ecosystem on the current challenges and opportunities of funding innovation at all stages of the innovation continuum -- from early research through late stage development and commercialization. The promise of science is exploding: gene therapy and gene editing offer potential cures; breakthroughs in understanding the human genome provide clues to more effectively develop targeted therapies; advances in harnessing the immune system to fight cancer are encouraging. As science progresses, how is the model for creating and financing these advancements evolving? Will the rapidly changing pricing and reimbursements dynamics for biomedical innovation continue to reward the entrepreneurs and innovators that take the risks to test and gain approval of new therapies? Join us and hear from a panel of experts that have focused much of their professional careers at the intersection of business, science and medicine.
Contact Name
Grace Taylor A.B. '91, P '18